Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Abcellera Biologics Inc (ABCL)

Abcellera Biologics Inc (ABCL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,770,798
  • Shares Outstanding, K 286,100
  • Annual Sales, $ 375,200 K
  • Annual Income, $ 153,460 K
  • 60-Month Beta -0.43
  • Price/Sales 9.81
  • Price/Cash Flow 21.23
  • Price/Book 2.94
Trade ABCL with:

Options Overview Details

View History
  • Implied Volatility 61.30% ( -4.87%)
  • Historical Volatility 51.87%
  • IV Percentile 2%
  • IV Rank 10.85%
  • IV High 105.19% on 07/28/22
  • IV Low 55.96% on 11/10/22
  • Put/Call Vol Ratio 5.14
  • Today's Volume 767
  • Volume Avg (30-Day) 1,260
  • Put/Call OI Ratio 0.41
  • Today's Open Interest 36,085
  • Open Int (30-Day) 37,266

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate 0.03
  • Number of Estimates 5
  • High Estimate 0.09
  • Low Estimate -0.03
  • Prior Year 0.19
  • Growth Rate Est. (year over year) -84.21%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.55 +10.01%
on 11/09/22
14.97 -15.10%
on 11/15/22
+0.71 (+5.92%)
since 11/02/22
3-Month
9.09 +39.82%
on 09/23/22
14.97 -15.10%
on 11/15/22
+1.87 (+17.25%)
since 09/02/22
52-Week
5.42 +134.50%
on 05/12/22
15.90 -20.06%
on 12/22/21
-2.12 (-14.30%)
since 12/02/21

Most Recent Stories

More News
AbCellera and Rallybio Announce Strategic Alliance to Discover, Develop, and Commercialize Novel Antibody-Based Therapeutics for Rare Diseases

AbCellera (Nasdaq: ABCL) and Rallybio Corporation (Nasdaq: RLYB) announced today that they have entered into a strategic alliance to discover, develop, and commercialize novel antibody-based therapeutics...

ABCL : 12.71 (-3.57%)
RLYB : 5.78 (-4.30%)
AbCellera Presents New Data on Further Development and Characterization of T-Cell Engager Platform at SITC 2022

AbCellera (Nasdaq: ABCL) today announced the release of new data on its T-cell engager (TCE) platform at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting, to be held virtually and at...

ABCL : 12.71 (-3.57%)
AbCellera Biologics Inc. (ABCL) Q3 2022 Earnings Call Transcript

ABCL earnings call for the period ending September 30, 2022.

ABCL : 12.71 (-3.57%)
AbCellera Biologics Inc. (ABCL) Q3 Earnings Miss Estimates

AbCellera Biologics Inc. (ABCL) delivered earnings and revenue surprises of -11.11% and 31.34%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the...

ABCL : 12.71 (-3.57%)
ALIM : 3.58 (+3.77%)
AbCellera Reports Q3 2022 Business Results

AbCellera (Nasdaq: ABCL), a technology company with a centralized operating system for next-generation antibody discovery, today announced financial results for the third quarter of 2022. All financial...

ABCL : 12.71 (-3.57%)
AbCellera to Present at Upcoming Investor Conferences in November

AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the following investor conferences:

ABCL : 12.71 (-3.57%)
AbCellera’s First Program with Regeneron in Multi-Target Collaboration Advances in Preclinical Development

AbCellera (Nasdaq: ABCL) announced today that Regeneron has elected to exercise its right to advance a therapeutic antibody candidate, discovered in partnership with AbCellera as part of a multi-target...

ABCL : 12.71 (-3.57%)
AbCellera Biologics Inc. (ABCL) Reports Next Week: Wall Street Expects Earnings Growth

AbCellera Biologics Inc. (ABCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ABCL : 12.71 (-3.57%)
NTLA : 46.12 (+0.70%)
Wall Street Analysts Believe AbCellera Biologics Inc. (ABCL) Could Rally 138%: Here's is How to Trade

The mean of analysts' price targets for AbCellera Biologics Inc. (ABCL) points to a 137.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement...

ABCL : 12.71 (-3.57%)
AbCellera to Report Third Quarter 2022 Financial Results on November 8, 2022

AbCellera (Nasdaq: ABCL) will announce its third quarter 2022 financial results on Tuesday, November 8, 2022, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the...

ABCL : 12.71 (-3.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

AbCellera Biologics Inc. is a technology company which searches, decodes and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera Biologics Inc. is based in Vancouver, Canada.

See More

Key Turning Points

3rd Resistance Point 14.02
2nd Resistance Point 13.55
1st Resistance Point 13.13
Last Price 12.71
1st Support Level 12.24
2nd Support Level 11.77
3rd Support Level 11.35

See More

52-Week High 15.90
Last Price 12.71
Fibonacci 61.8% 11.90
Fibonacci 50% 10.66
Fibonacci 38.2% 9.42
52-Week Low 5.42

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar